Publications of Olaf Jahn

Chatterjee, M.; Özdemir, S.; Kunadt, M.; Koel-Simmelink, M.; Boiten, W.; Piepkorn, L.; Pham, T. V.; Chiasserini, D.; Piersma, S. R.; Knol, J. C. et al.; Möbius, W.; Mollenhauer, B.; van der Flier, W. M.; Jimenez, C. R.; Teunissen, C. E.; Jahn, O.; Schneider, A.: C1q is increased in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: A multi-cohort proteomics and immuno-assay validation study. Alzheimer's & Dementia, in press (2023)

Liepold, T.; Klafki, H.-W.; Kumar, S.; Walter, J.; Wirths, O.; Wiltfang, J.; Jahn, O.: Matrix Development for the Detection of Phosphorylated Amyloid-β Peptides by MALDI-TOF-MS. Journal of the American Society for Mass Spectrometry 34 (3), pp. 505 - 512 (2023)

Bader, A. S.; Gnädig, M.-U.; Fricke, M.; Büschgens, L.; Berger, L. J.; Klafki, H.-W.; Meyer, T.; Jahn, O.; Weggen, S.; Wirths, O.: Brain Region-Specific Differences in Amyloid-β Plaque Composition in 5XFAD Mice. Life 13 (4), 1053 (2023)

Klafki, H.-W.; Morgado, B.; Wirths, O.; Jahn, O.; Bauer, C.; Esselmann, H.; Schuchhardt, J.; Wiltfang, J.: Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40? Fluids and Barriers of the CNS 19 (1), 96 (2022)

Düking, T.; Spieth, L.; Berghoff, S. A.; Piepkorn, L.; Schmidke, A. M.; Mitkovski, M.; Kannaiyan, N.; Hosang, L.; Scholz, P.; Shaib, A. H. et al.; Schneider, L. V.; Hesse, D.; Ruhwedel, T.; Sun, T.; Linhoff, L.; Trevisiol, A.; Köhler, S.; Pastor, A. M.; Misgeld, T.; Sereda, M.; Hassouna, I.; Rossner, M. J.; Odoardi, F.; Ischebeck, T.; de Hoz, L.; Hirrlinger, J.; Jahn, O.; Saher, G.: Ketogenic diet uncovers differential metabolic plasticity of brain cells. Science Advances 8 (37), eabo7639 (2022)

Gargareta, V.-I.; Reuschenbach, J.; Siems, S. B.; Sun, T.; Piepkorn, L.; Mangana, C.; Späte, E.; Goebbels, S.; Huitinga, I.; Möbius, W. et al.; Nave, K.-A.; Jahn, O.; Werner, H. B.: Conservation and divergence of myelin proteome and oligodendrocyte transcriptome profiles between humans and mice. eLife 11, e77019 (2022)

Buscham, T. J.; Eichel-Vogel, M. A.; Steyer, A. M.; Jahn, O.; Strenzke, N.; Dardawal, R.; Memhave, T. R.; Siems, S. B.; Müller, C.; Meschkat, M. et al.; Sun, T.; Ruhwedel, T.; Möbius, W.; Krämer-Albers, E.-M.; Boretius, S.; Nave, K.-A.; Werner, H. B.: Progressive axonopathy when oligodendrocytes lack the myelin protein CMTM5. eLife 11, e75523 (2022)

Meschkat, M.; Steyer, A. M.; Weil, M.-T.; Kusch, K.; Jahn, O.; Piepkorn, L.; Agüi-Gonzalez, P.; Phan, N. T. N.; Ruhwedel, T.; Sadowski, B. et al.; Rizzoli, S. O.; Werner, H. B.; Ehrenreich, H.; Nave, K.-A.; Möbius, W.: White matter integrity in mice requires continuous myelin synthesis at the inner tongue. Nature Communications 13, 1163 (2022)

Klafki, H.-W.; Wirths, O.; Mollenhauer, B.; Liepold, T.; Rieper, P.; Esselmann, H.; Vogelsang, J.; Wiltfang, J.; Jahn, O.: Detection and quantification of Aβ−3–40 (APP669‐711) in cerebrospinal fluid. Journal of Neurochemistry 160 (5), pp. 578 - 589 (2022)

Siems, S. B.; Jahn, O.; Hoodless, L. J.; Jung, R. B.; Hesse, D.; Möbius, W.; Czopka, T.; Werner, H. B.: Proteome Profile of Myelin in the Zebrafish Brain. Frontiers in Cell and Developmental Biology 9, 640169 (2021)

Ambrozkiewicz, M.; Borisova, E.; Schwark, M.; Ripamonti, S.; Schaub, T.; Smorodchenko, A.; Weber, A. I.; Rhee, H. J.; Altas, B.; Yilmaz, R. et al.; Mueller, S.; Piepkorn, L.; Horan, S. T.; Straussberg, R.; Zaqout, S.; Jahn, O.; Dere, E.; Rosário, M.; Boehm-Sturm, P.; Borck, G.; Willig, K. I.; Rhee, J. S.; Tarabykin, V.; Kawabe, H.: The murine ortholog of Kaufman oculocerebrofacial syndrome protein Ube3b regulates synapse number by ubiquitinating Ppp3cc. Molecular Psychiatry 26, pp. 1980 - 1995 (2021)

Klafki, H. W.; Rieper, P.; Matzen, A.; Zampar, S.; Wirths, O.; Vogelgsang, J.; Osterloh, D.; Rohdenburg, L.; Oberstein, T. J.; Jahn, O. et al.; Beyer, I.; Lachmann, I.; Knölker, H.-J.; Wiltfang, J.: Development and Technical Validation of an Immunoassay for the Detection of APP669–711 (Aβ−3–40) in Biological Samples. International Journal of Molecular Sciences 21 (18), 6564 (2020)

Jahn, O.; Siems, S. B.; Kusch, K.; Hesse, D.; Jung, R. B.; Liepold, T.; Uecker, M.; Sun, T.; Werner, H. B.: The CNS Myelin Proteome: Deep Profile and Persistence After Post-mortem Delay. Frontiers in Cellular Neuroscience 14, 249 (2020)

Dihazi, G. H.; Eltoweissy, M.; Jahn, O.; Tampe, B.; Zeisberg, M.; Wülfrath, H. S.; Müller, G. A.; Dihazi, H.: The secretome analysis of activated human renal fibroblasts revealed beneficial effect of the modulation of the secreted peptidyl-prolyl cis-trans isomerase A in kidney fibrosis. Cells 9 (7), 1724 (2020)

Ripamonti, S.; Shomroni, O.; Rhee, J.; Chowdhury, K.; Jahn, O.; Hellmann, K.; Bonn, S.; Brose, N.; Tirard, M.: SUMOylation controls the neurodevelopmental function of the transcription factor Zbtb20. Journal of Neurochemistry: official journal of the International Society for Neurochemistry 154 (6), pp. 647 - 661 (2020)

Siems, S. B.; Jahn, O.; Eichel, M. A.; Kannaiyan, N.; Wu, L. M. N.; Sherman, D. L.; Kusch, K.; Hesse, D.; Jung, R. B.; Fledrich, R. et al.; Sereda, M. W.; Rossner, M. J.; Brophy, P. J.; Werner, H. B.: Proteome profile of peripheral myelin in healthy mice and in a neuropathy model. eLife 9, e51406 (2020)

Koziolek, M.; Mueller, G. A.; Dihazi, G. H.; Jung, K.; Altubar, C.; Wallbach, M.; Markovic, I.; Raddatz, D.; Jahn, O.; Karaköse, H. et al.; Lenz, C.; Urlaub, H.; Dihazi, A.; El Meziane, A. E.; Dihazi, H.: Urine E-cadherin: A marker for early detection of kidney injury in diabetic patients. Journal of Clinical Medicine 9, 639 (2020)

Piotrowski, C.; Moretti, R.; Ihling, C. H.; Haedicke, A.; Liepold, T.; Lipstein, N.; Meiler, J.; Jahn, O.; Sinz, A.: Delineating the molecular basis of the calmodulin–bMunc13-2 interaction by cross-linking/mass spectrometry—evidence for a novel CaM binding motif in bMunc13-2. Cells 9, 136 (2020)

Akula, A. K.; Zhang, X.; Viotti, J. S.; Nestvogel, D. B.; Rhee, H. J.; Ebrecht, R.; Reim, K.; Wouters, F.; Liepold, T.; Jahn, O. et al.; Bogeski, I.; Dresbach, T.: The Calmodulin Binding Region of the Synaptic Vesicle Protein Mover Is Required for Homomeric Interaction and Presynaptic Targeting. EPJ Web of Conferences 12, 249 (2019)

Joseph, S.; Vingill, S.; Jahn, O.; Fledrich, R.; Werner, H. B.; Katona, I.; Möbius, W.; Mitkovski, M.; Huang, Y.; Weis, J. et al.; Sereda, M. W.; Schulz, J. B.; Nave, K.-A.; Stegmüller, J.: Myelinating glia-specific deletion of Fbxo7 in mice triggers axonal degeneration in the central nervous system together with peripheral neuropathy. The Journal of Neuroscience 39 (28), pp. 5606 - 5626 (2019)